Wěi Li

Researcher Next ID · RN-005235

Researcher · Medicine

Xiaodian, China

Not currently recruitingFunding unknown

Research interests

Medicine

Chemistry

Lung Cancer Treatments and Mutations

Synthesis and biological activity

HER2/EGFR in Cancer Research

Cancer Treatment and Pharmacology

Click Chemistry and Applications

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2203690
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1706450
HIF-1α pathway: role, regulation and intervention for cancer therapy
Acta Pharmaceutica Sinica B · 2015 · https://doi.org/10.1016/j.apsb.2015.05.007
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(13)70604-1
An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
Pharmaceutical Research · 2012 · https://doi.org/10.1007/s11095-012-0828-z

No projects listed.